SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) /
The profitability of SCINAI IMMUNOTHERAPEUTICS LTD. over the past 5 years
Chart SCINAI IMMUNOTHERAPEUTICS LTD.: gross profit, operating income, net income, fiscal 2021–2025 Open the chart →SCINAI IMMUNOTHERAPEUTICS LTD. reported a net loss of $8.31M in fiscal 2025, the latest fiscal year on file. That year it had a gross loss of $2.65M and an operating loss of $7.54M. It reported a profit in 1 of the 5 years shown, and a loss in fiscal 2021, 2022, 2023 and 2025. Its highest net income in these years was $4.8M, in fiscal 2024.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | -$2.65M | -$7.54M | -$8.31M |
| 2024ended Dec 31, 2024 | -$580K | -$8.64M | $4.8M |
| 2023ended Dec 31, 2023 | — | -$9.71M | -$6.5M |
| 2022ended Dec 31, 2022 | — | -$11.06M | -$5.8M |
| 2021ended Dec 31, 2021 | — | -$10.86M | -$8.21M |
Fiscal years as SCINAI IMMUNOTHERAPEUTICS LTD. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on SCINAI IMMUNOTHERAPEUTICS LTD.
- The cash flow of SCINAI IMMUNOTHERAPEUTICS LTD.
- The debt of SCINAI IMMUNOTHERAPEUTICS LTD.
- All of SCINAI IMMUNOTHERAPEUTICS LTD.'s financials, charted
Companies of a similar size
- PIIMPINJ, INC.
- NXSTNEXSTAR MEDIA GROUP, INC.
- HASIHA SUSTAINABLE INFRASTRUCTURE CAPITAL, INC.
- PSMTPriceSmart, Inc.
- AXAxos Financial, Inc.
Not investment advice. This page shows what SCINAI IMMUNOTHERAPEUTICS LTD. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.